Does Gender Influence Differences in Mortality and Length of Stay in Hospitalized Patients Admitted with COVID-19
Main Article Content
Abstract
Background: Gender disparities have previously been reported to influence outcomes of various illnesses, including viral illness such as respiratory syncytial virus and COVID-19 virus. Males have previously been found to be more susceptible to infection and complications of such diseases.
Objective: The idea that there are differential impacts by gender on morbidity and mortality of COVID-19 patients admitted to the hospital as well as identifying any confounding factors that might contribute to such disparities were investigated.
Design: Retrospective study of patients 65 years and older admitted with COVID-19 infection between February 2020 and February 2022 were included.
Setting: Community teaching hospital in Michigan.
Participants: All consecutive patients , age 18 years and older, all gender and race with a positive diagnosis for COVID-19 were included in the study.
Measurements: Incidence of complications and mortality were measured in both males and females and differences calculated.
Results: The 963 patients were divided into two groups: males (n= 483), and females (n=480). The mortality rate for males (n=341, 70.6%), and females (n=345, 71.9%) were similar. However, there were more females with less than 4 associated comorbid conditions compared to males (80.8% vs 70.0%, p=0.0001) and the females had a higher mortality rate (71.9% vs. 70.6%, p=0.66). There were more males with 4 or more associated comorbid conditions and this was significantly higher than in the female group (30.0% vs 19.2%, p=0.0001).
Limitations: There was no data collected following discharge from the hospital in regard to late complications.
Conclusions: Kidney disease is a significant predictor of mortality of our COVID-19 patients admitted to our hospital, additionally COPD had a similar impact on mortality but only in the female patients.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
2. Sun J, He W-T, Wang L., et. al . COVID-19: epidemiology, evolution , and cross Disciplinary perspectives. Trends Mol Med. 2020;26:483-495.
3. Li X, Geng M, Peng Y, Meng L, Lu S. Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal.2020;10:102-108.
4. Zhou F, Yu T, Du R, et. al. Clinical course and risk factors for mortality of adult Inpatients with COVID-19 IN Wuhan,China: A retrospective cohort study. Lancet. 2020;395:1054-1062.
5. Rhines AS. The role of sex differences in the prevalence and transmission of tuberculosis. Tuberculosis (Edinb). 2013;93(1):104-107. doi:10.1016/j.tube.2012.10.012.
6. Zhang X, Andersen AB, Lillebaek T, et al. Effect of sex, age, and race on the clinical presentation of tuberculosis: a 15-year population-based study. Am J Trop Med Hyg. 2011;85(2):285-290. doi:10.4269/ajtmh.2011.10-0630.
7. Menzaghi B, Ricci E, Vichi F, et al. Gender differences in HIV infection: is there a problem? Analysis from the SCOLTA cohorts. Biomed Pharmacother. 2014;68(3):385-390. doi:10.1016/j.biopha.2014.01.007.
8. Chanana N, Palmo T, Sharma K, Kumar R, Graham BB, Pasha Q. Sex-derived attributes contributing to SARS-CoV-2 mortality. Am J Physiol Endocrinol Metab. 2020;319(3):E562-E567. doi:10.1152/ajpendo.00295.2020.
9. Ambrosino I, Barbagelata E, Corbi G, Ciarambino T, Politi C, Moretti AM. Gender differences in treatment of Coronavirus Disease-2019. Monaldi Arch Chest Dis. 2020; 90(4):10.4081/monaldi.2020.1508. Published 2020 Dec 3. doi:10.4081/monaldi.2020.1508.
10. Takahashi T, Ellingson MK, Wong P, et al. Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature. 2020;588(7837):315-320. doi:10.1038/s41586-020-2700-3.
11. Toubasi AA, AbuAnzeh RB, Tawileh HBA, Aldebei RH, Alryalat SAS. A meta-analysis: The mortality and severity of COVID-19 among patients with mental disorders. Psychiatry Res. 2021; 299:113856. doi:10.1016/j.psychres.2021.113856.
12. Momen NC, Plana-Ripoll O, Agerbo E, et al. Association between Mental Disorders and Subsequent Medical Conditions. N Engl J Med. 2020;382(18):1721-1731. doi:10.1056/NEJMoa1915784.
13. Scully EP, Haverfield J, Ursin RL, Tannenbaum C, Klein SL. Considering how biological sex impacts immune responses and COVID-19 outcomes. Nat Rev Immunol. 2020;20(7):442-447. doi:10.1038/s41577-020-0348-8.
14. Gebhard C, Regitz-Zagrosek V, Neuhauser HK, Morgan R, Klein SL. Impact of sex and gender on COVID-19 outcomes in Europe. Biol Sex Differ. 2020;11(1):29. Published 2020 May 25. doi:10.1186/s13293-020-00304-9.
15. Alwani M, Yassin A, Al-Zoubi RM, et al. Sex-based differences in severity and mortality in COVID-19. Rev Med Virol. 2021;31(6):e2223. doi:10.1002/rmv.2223.
16. Lau SK, Lee P, Tsang AK, et al. Molecular epidemiology of human coronavirus OC43 reveals evolution of different genotypes over time and recent emergence of a novel genotype due to natural recombination. J Virol. 2011;85(21):11325-11337. doi:10.1128/JVI.05512-11.
17. Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708-1720. doi:10.1056/NEJMoa2002032.
18. Jayawardena R, Jeyakumar DT, Misra A, Hills AP, Ranasinghe P. Obesity: A potential risk factor for infection and mortality in the current COVID-19 epidemic. Diabetes Metab Syndr. 2020;14(6):2199-2203. doi:10.1016/j.dsx.2020.11.001.
19. Pan XW, Xu D, Zhang H, Zhou W, Wang LH, Cui XG. Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis. Intensive Care Med. 2020;46(6):1114-1116. doi:10.1007/s00134-020-06026-1.
20. Rajpal A, Rahimi L, Ismail-Beigi F. Factors leading to high morbidity and mortality of COVID-19 in patients with type 2 diabetes. J Diabetes. 2020;12(12):895-908. doi:10.1111/1753-0407.13085.
21. Channappanavar R, Fett C, Mack M, Ten Eyck PP, Meyerholz DK, Perlman S. Sex-Based Differences in Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Infection. J Immunol. 2017;198(10):4046-4053. doi:10.4049/jimmunol.1601896.
22. Ambrosino I, Barbagelata E, Ortona E, et al. Gender differences in patients with COVID-19: a narrative review. Monaldi Arch Chest Dis. 2020;90(2):10.4081/monaldi.2020.1389. Published 2020 May 25. doi:10.4081/monaldi.2020.1389.
23. Agrawal H, Das N, Nathani S, et al. An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner. Stem Cell Rev Rep. 2021;17(1):94-112. doi:10.1007/s12015-020-10048-z.
24. Bunders MJ, Altfeld M. Implications of Sex Differences in Immunity for SARS-CoV-2 Pathogenesis and Design of Therapeutic Interventions. Immunity. 2020;53(3):487-495. doi:10.1016/j.immuni.2020.08.003.
25. Haq K, Mahmood F, Ghaly M. Renal manifestations, incidence, pathogenesis and implications on prognosis and mortality in COVID-19 patients: A review of current evidence and the potential for future directions. Clin Nephrol. 2021;96(2):67-81. doi:10.5414/CN110366.
26. Glass WG, Subbarao K, Murphy B, Murphy PM. Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice. J Immunol. 2004;173(6):4030-4039. doi:10.4049/jimmunol.173.6.4030.
27. Cheng Y, Luo R, Wang K, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829-838. doi:10.1016/j.kint.2020.03.005.
28. Oyelade T, Alqahtani J, Canciani G. Prognosis of COVID-19 in Patients with Liver and Kidney Diseases: An Early Systematic Review and Meta-Analysis. Trop Med Infect Dis. 2020;5(2):80. Published 2020 May 15. doi:10.3390/tropicalmed5020080.
29. Cai R, Zhang J, Zhu Y, Liu L, Liu Y, He Q. Mortality in chronic kidney disease patients with COVID-19: a systematic review and meta-analysis. Int Urol Nephrol. 2021;53(8):1623-1629. doi:10.1007/s11255-020-02740-3.
30. Imig JD, Ryan MJ. Immune and inflammatory role in renal disease. Compr Physiol. 2013;3(2):957-976. doi:10.1002/cphy.c120028.
31. Richardson S, Hirsch JS, Narasimhan M, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area [published correction appears in JAMA. 2020 May 26;323(20):2098. doi: 10.1001/jama.2020.7681]. JAMA. 2020;323(20):2052-2059. doi:10.1001/jama.2020.6775.
32. Argenziano MG, Bruce SL, Slater CL, et al. Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series. BMJ. 2020;369:m1996. Published 2020 May 29. doi:10.1136/bmj.m1996.